Animal Health

Replicon Particle Porcine Reproductive and Respiratory Syndrome Virus Vaccine Provides Partial Protection from Challenge

Authors
  • Mark Mogler (Iowa State University)
  • D.L. Hank Harris (Iowa State University)
  • Matthew M. Erdman (Iowa State University)
  • Kurt I. Kamrud (AlphaVax, Inc.)

Abstract

Replicon particles (RPs) expressing the GP5 and Matrix structural proteins of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) were created and compared to inactivated PRRSV in a challenge study. Pigs that received the RP vaccine had lower live virus titers and showed lower IDEXX ELISA values following challenge when compared to other groups.

These results show that the RP vaccine provided partial protection against challenge with virulent PRRSV. Also, the RP vaccine allows for differentiation between vaccinated and naturally infected animals.

Keywords: ASL R2382

How to Cite:

Mogler, M., Harris, D. H., Erdman, M. M. & Kamrud, K. I., (2009) “Replicon Particle Porcine Reproductive and Respiratory Syndrome Virus Vaccine Provides Partial Protection from Challenge”, Iowa State University Animal Industry Report 6(1). doi: https://doi.org/10.31274/ans_air-180814-23

Downloads:
Download pdf

253 Views

74 Downloads

Published on
01 Jan 2009
Peer Reviewed